(E)-N-(3-Methyl-1-butenyl)benzamid | 78007-45-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (E)-N-(3-Methyl-1-butenyl)benzamid
• 英文别名: N-[(E)-3-methylbut-1-enyl]benzamide
• CAS: 78007-45-1
• 化学式: C₁₂H₁₅NO
• 分子量: 189.257
• InChiKey: ZEPDLCOSUWSUCF-CMDGGOBGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  4-异丁基-2-苯基-2-噁唑啉-5-酮 550.0 ℃ 、26.66 Pa 条件下， 生成 (Z)-N-(3-Methyl-1-butenyl)benzamid 、 (E)-N-(3-Methyl-1-butenyl)benzamid
  参考文献：
  名称：

  Jendrzejewski, Stefan; Steglich, Wolfgang, Chemische Berichte, 1981, vol. 114, # 4, p. 1337 - 1342

  摘要：

  DOI：

文献信息

• Cytotoxin compounds and methods of isolation
  申请人：UNIVERSITY OF SOUTH FLORIDA

  公开号：US10815212B2

  公开（公告）日：2020-10-27

  The present invention concerns groups of compounds derived from tunicates of the Synoicum species, as well as to pharmaceutical compositions comprising these compounds, and uses thereof. Extracts from tunicates show selective toxicity against several different cancer cell lines in the NCI 60 cell line panel. These compounds are useful in the effective treatment of cancers, particularly malignant melanomas, colon cancer, and renal cancer cell lines.

  本发明涉及从鳞栉水母属鳞栉水母中提取的几组化合物，以及包含这些化合物的药物组合物及其用途。鳞茎萃取物对 NCI 60 细胞系中几种不同的癌细胞系具有选择性毒性。这些化合物可用于有效治疗癌症，特别是恶性黑色素瘤、结肠癌和肾癌细胞系。
• Cytotoxin Compounds and Methods of Isolation
  申请人：Baker Bill

  公开号：US20090192215A1

  公开（公告）日：2009-07-30

  The present invention concerns groups of compounds derived from tunicates of the Synoicum species, as well as to pharmaceutical compositions comprising these compounds, and uses thereof. Extracts from tunicates show selective toxicity against several different cancer cell lines in the NCI 60 cell line panel. These compounds are useful in the effective treatment of cancers, particularly malignant melanomas, colon cancer, and renal cancer cell lines.
• CYTOTOXIN COMPOUNDS AND METHODS OF ISOLATION
  申请人：THE UAB RESEARCH FOUNDATION

  公开号：US20140194495A1

  公开（公告）日：2014-07-10

  The present invention concerns groups of compounds derived from tunicates of the Synoicum species, as well as to pharmaceutical compositions comprising these compounds, and uses thereof. Extracts from tunicates show selective toxicity against several different cancer cell lines in the NCI 60 cell line panel. These compounds are useful in the effective treatment of cancers, particularly malignant melanomas, colon cancer, and renal cancer cell lines.
• US8669376B2
  申请人：——

  公开号：US8669376B2

  公开（公告）日：2014-03-11
• US9394270B2
  申请人：——

  公开号：US9394270B2

  公开（公告）日：2016-07-19